NEW ORLEANS (WGNO) — The Kennedy Cougars shut out the Livingston Collegiate Wolves, 27-0 on Thursday night. The Cougars improve to 5-3 on the season and will face the De La Salle Cavaliers next week.

ALBANY, La. (WGNO) —The Amite Warriors won a dominant 35-0 game over the Albany Hornets. The Warriors improved to 7-2 (3-0) on the season. You can catch more high school football action on Season 34 ...

PANAMA CITY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The final quarter of 2025 is shaping into a turning point for decentralized finance. Solana (SOL) continues to attract attention with record throughput ...

Safety primary endpoint achieved Median treatment duration of 4 months with a range of 2 to 12 months and three patients remain on trial RECIST data with apparent stable disease lasting over 4 months ...

Satisfactory (1.0) - 11 Things To Know Before Starting | Phase 1 Guide Satisfactory has been around for a while now, having spent five years in Early Access. It’s transformed quite a bit since ...

Russia has accused the U.K. of plotting a sabotage operation in a move that shows Moscow is setting the conditions for a conflict with NATO, according to the Institute for the Study of War (ISW). That ...

VaporTheGamer reacts to tricky mod phase 3 is literal madness! [part 1] with fun commentary, unique insights, and FNAF or FNF fan excitement. VIDEO: Hay fraud hits local farms Flooded outfield results ...

VaporTheGamer reacts to skeleton tricky phase 5 and minecraft steve in friday night funkin'! (friday night mining/tricky 5) with fun commentary, unique insights, and FNAF or FNF fan excitement.

Keir Starmer has described his shake-up in Downing Street as the "second phase" of his government, insisting it is not a "reshuffle". In a radio interview with the BBC's Matt Chorley, the prime ...

ENTERPRISE, Ala. (WTVY) - Enterprise’s Mason Burkhardt is our 2025 Week 0 Friday Night Football Player of the Week! Burkhardt showed off some great talent behind center to lead the Wildcats to their ...

Asciminib, a first-in-class BCR-ABL1 TKI, showed high molecular response rates and was well tolerated in the first prospective trial of its kind evaluating the drug as a dose-escalated second-line ...